HAE Clinical Trials

227 recruitingLast updated: May 21, 2026

There are 227 actively recruiting hae clinical trials across 65 countries. Studies span Not Applicable, Phase 3, Phase 2, Phase 1, Phase 4, Early Phase 1. Top locations include London, United Kingdom, Southampton, United Kingdom, Cambridge, United Kingdom. Updated daily from ClinicalTrials.gov.


HAE Trials at a Glance

227 actively recruiting trials for hae are listed on ClinicalTrialsFinder across 6 cities in 65 countries. The largest study group is Not Applicable with 44 trials, with the heaviest enrollment activity in London, Southampton, and Cambridge. Lead sponsors running hae studies include Cancer Research UK, Novo Nordisk A/S, and Royal Brisbane and Women's Hospital.

About HAE Clinical Trials

Looking for clinical trials for HAE? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HAE trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HAE clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 227 trials

Recruiting
Not Applicable

Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors

StrokeIschemic StrokeTIA (Transient Ischemic Attack)+1 more
Massachusetts General Hospital150 enrolled2 locationsNCT07414732
Recruiting
Phase 3

Donidalorsen Treatment in Children With Hereditary Angioedema

Hereditary Angioedema (HAE)
Ionis Pharmaceuticals, Inc.20 enrolled8 locationsNCT07298447
Recruiting
Not Applicable

A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Hereditary Angioedema (HAE)
Takeda514 enrolled1 locationNCT07293364
Recruiting
Phase 3

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Hereditary AngioedemaHereditary Angioedema - Type 1Hereditary Angioedema - Type 2+1 more
ADARx Pharmaceuticals, Inc.90 enrolled51 locationsNCT06960213
Recruiting

Translational Immunodiagnostics in Stroke (TrImS)

Atrial FibrillationAcute Ischemic StrokeCardioembolic Stroke+9 more
The University of Hong Kong650 enrolled1 locationNCT05300997
Recruiting
Phase 3

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V.170 enrolled62 locationsNCT06679881
Recruiting

A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia

Hereditary Angioedema (HAE)
Takeda50 enrolled1 locationNCT07263685
Recruiting
Not Applicable

Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidS

HAEHemorrhoids, InternalHemorrhoidal Bleeding+1 more
Jessica K. Stewart, MD40 enrolled1 locationNCT07559630
Recruiting
Not Applicable

Pulsatile Flushing Technique in Reducing Blockage of T-CVAD for Haemodialysis Patients

haemodialysis patientsBlockage of Tunnelled Central Venous Access DevicePulsatile Flushing Technique
Queen Elizabeth Hospital, Hong Kong591 enrolled1 locationNCT07567456
Recruiting
Phase 1Phase 2

Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients

Haemodynamic Rebound
New Valley University2 enrolled1 locationNCT06490731
Recruiting
Phase 3

A Study of Navenibart in Participants With Hereditary Angioedema

Hereditary Angioedema (HAE)
Astria Therapeutics, Inc.145 enrolled87 locationsNCT06842823
Recruiting

IMPACT OF DIALYSIS DURATION AND DIURESIS ON BLADDER CAPACITY AND COMPLIANCE IN END STAGE RENAL DISEASE PATIENTS AWAITING RENAL TRANSPLANT

Bladder DysfunctionEnd-Stage Renal Disease Requiring Haemodialysis
Sindh Institute of Urology and Transplantation87 enrolled1 locationNCT07570771
Recruiting

A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries

Hereditary Angioedema (HAE)
Takeda40 enrolled24 locationsNCT07251933
Recruiting

Synovial Proliferation on Routine Ultrasound: Active or Inactive?

HaemophiliaHemophilia AHemophilia B
Van Creveldkliniek46 enrolled1 locationNCT06809972
Recruiting
Phase 3

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

Autoimmune Haemolytic Anaemia
Sanofi90 enrolled92 locationsNCT07086976
Recruiting
Phase 3

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

Hereditary Angioedema (HAE)Hereditary Angioedema - Type 1Hereditary Angioedema - Type 2+1 more
ADARx Pharmaceuticals, Inc.90 enrolled48 locationsNCT07428499
Recruiting
Phase 1

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

Haemophilia A
Novo Nordisk A/S30 enrolled33 locationsNCT07220564
Recruiting

A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI

Haemophilia A
Haemophilia Centre Rhine Main300 enrolled1 locationNCT02207894
Recruiting
Phase 2

Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)

Haemophagocytic Lymphohistiocytosis
Assistance Publique - Hôpitaux de Paris20 enrolled1 locationNCT05762640
Recruiting
Phase 3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Haemophilia A (Moderate or Severe)
Swedish Orphan Biovitrum104 enrolled24 locationsNCT06716814